These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 24887083)
1. Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation. Wang B; Yang Q; Bai WW; Xing YF; Lu XT; Sun YY; Zhao YX PLoS One; 2014; 9(6):e98047. PubMed ID: 24887083 [TBL] [Abstract][Full Text] [Related]
2. Tongmai Yangxin pill reduces myocardial no-reflow by regulating apoptosis and activating PI3K/Akt/eNOS pathway. Chen R; Chen T; Wang T; Dai X; Meng K; Zhang S; Jiang D; Wang Y; Zhou K; Geng T; Xu J; Wang Y J Ethnopharmacol; 2020 Oct; 261():113069. PubMed ID: 32619593 [TBL] [Abstract][Full Text] [Related]
3. Tongxinluo Activates PI3K/AKT Signaling Pathway to Inhibit Endothelial Mesenchymal Transition and Attenuate Myocardial Fibrosis after Ischemia-Reperfusion in Mice. Wei YR; Hou YL; Yin YJ; Li Z; Liu Y; Han NX; Wang ZX; Liu L; Wang XQ; Hao YJ; Ma K; Gu JJ; Jia ZH Chin J Integr Med; 2024 Jul; 30(7):608-615. PubMed ID: 38386252 [TBL] [Abstract][Full Text] [Related]
4. Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway. Liu X; Wu J; Zhu C; Liu J; Chen X; Zhuang T; Kuang Y; Wang Y; Hu H; Yu P; Fan H; Zhang Y; Liu Z; Zhang L J Cell Mol Med; 2020 Jan; 24(2):2013-2026. PubMed ID: 31854513 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice. Park CW; Kim HW; Lim JH; Yoo KD; Chung S; Shin SJ; Chung HW; Lee SJ; Chae CB; Kim YS; Chang YS Diabetes; 2009 Nov; 58(11):2666-76. PubMed ID: 19675133 [TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury. Chen G; Xu C; Gillette TG; Huang T; Huang P; Li Q; Li X; Li Q; Ning Y; Tang R; Huang C; Xiong Y; Tian X; Xu J; Xu J; Chang L; Wei C; Jin C; Hill JA; Yang Y Theranostics; 2020; 10(25):11754-11774. PubMed ID: 33052245 [No Abstract] [Full Text] [Related]
8. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice. Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure. Westermann D; Riad A; Richter U; Jäger S; Savvatis K; Schuchardt M; Bergmann N; Tölle M; Nagorsen D; Gotthardt M; Schultheiss HP; Tschöpe C Basic Res Cardiol; 2009 Sep; 104(5):499-509. PubMed ID: 19255799 [TBL] [Abstract][Full Text] [Related]
10. Naoxintong inhibits myocardial infarction injury by VEGF/eNOS signaling-mediated neovascularization. Wang H; Qiu L; Ma Y; Zhang L; Chen L; Li C; Geng X; You X; Gao X J Ethnopharmacol; 2017 Sep; 209():13-23. PubMed ID: 28669772 [TBL] [Abstract][Full Text] [Related]
11. Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway. Li XD; Yang YJ; Geng YJ; Jin C; Hu FH; Zhao JL; Zhang HT; Cheng YT; Qian HY; Wang LL; Zhang BJ; Wu YL Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1255-61. PubMed ID: 20693395 [TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of pitavastatin on cardiac performance and remodeling in failing rat hearts. Kobayashi N; Takeshima H; Fukushima H; Koguchi W; Mamada Y; Hirata H; Machida Y; Shinoda M; Suzuki N; Yokotsuka F; Tabei K; Matsuoka H Am J Hypertens; 2009 Feb; 22(2):176-82. PubMed ID: 19039310 [TBL] [Abstract][Full Text] [Related]
13. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634 [TBL] [Abstract][Full Text] [Related]
15. Shexiang Tongxin Dropping Pill Promotes Angiogenesis through VEGF/eNOS Signaling Pathway on Diabetic Coronary Microcirculation Dysfunction. Cui XY; Liu TH; Bai YL; Zhang MD; Li GD; Zhang YT; Yuan YY; Zhang YW; Yu LS; Han LN; Wu Y Chin J Integr Med; 2024 Oct; 30(10):886-895. PubMed ID: 38753274 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress regulates left ventricular PDE5 expression in the failing heart. Lu Z; Xu X; Hu X; Lee S; Traverse JH; Zhu G; Fassett J; Tao Y; Zhang P; dos Remedios C; Pritzker M; Hall JL; Garry DJ; Chen Y Circulation; 2010 Apr; 121(13):1474-83. PubMed ID: 20308615 [TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Zhang P; Xu X; Hu X; van Deel ED; Zhu G; Chen Y Circ Res; 2007 Apr; 100(7):1089-98. PubMed ID: 17363700 [TBL] [Abstract][Full Text] [Related]
18. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Kobayashi N; Yoshida K; Nakano S; Ohno T; Honda T; Tsubokou Y; Matsuoka H Hypertension; 2006 Apr; 47(4):671-9. PubMed ID: 16505212 [TBL] [Abstract][Full Text] [Related]
19. [Effect of Tongxinluo on Apoptosis of Rat Cardiac Microvascular Endothelial Cells]. Wei G; Li HR; Liu HL; Yao B; Chen M; Liang JQ; Jia ZH; Wu YL Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):709-17. PubMed ID: 27491231 [TBL] [Abstract][Full Text] [Related]
20. Guan Xin Dan Shen formulation protects Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]